GE HealthCare Q3 2026: EPS Beats Expectations, Guidance Raised
As seen on the 24/7 Wall St. homepage on October 28, 2026.
The segment investors had flagged as the weak link, Patient Care Solutions, expanded EBIT margin 480 basis points to 8.6%. That turnaround backs the raised full-year adjusted EPS guidance.
Continue ReadingShow less
GE HealthCare posted adjusted earnings per share of $1.34 for the third quarter of 2026, beating expectations and clearing the high end of the analyst range.
Patient Care Solutions, the segment that drew the most investor skepticism heading into this quarter, expanded its EBIT margin by 480 basis points to 8.6%. That recovery resets the bear case on the business.
Free cash flow nearly doubled to $793 million, giving management the flexibility to fund its planned acquisition of SOFIE Biosciences and build out a PET radiopharmaceutical supply network in the United States.
Sponsored
Twelve Tabs, One Thesis
Your Research Resets Every Morning
The quote page in one tab. Filings in another. A chart you rebuilt from scratch, a transcript you never went back and found, a screener whose settings you will redo next week. Nothing you built yesterday is still there.
AlphaSpace replaces all of it with one screen you arrange yourself. Earnings calendar, estimate versus actual, the call transcript, live news, your own charts, every panel wired to whatever ticker you click. Close the browser and it is all still sitting there tomorrow.
See What a Built View Looks Like →
(Sponsor)
Management raised full-year 2026 adjusted EPS guidance to a range of $4.95 to $5.05, backed by a $23.7 billion backlog and 4% organic order growth.
The company also raised its quarterly dividend by 14% to $0.04 per share, with a record date of October 23, 2026. Keep an eye on the stock into year-end for whether the Patient Care Solutions margin recovery holds and whether China conditions stabilize.
Mentioned: GEHC